EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination

Xinfang Yu, Wei Li, Haidan Liu, Xu Wang, Cristian Coarfa, Chao Cheng, Xinlian Yu, Zhaoyang Zeng, Ya Cao, Ken H Young, Yong Li

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci160456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Xinfang Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: B7-H1 Antigen, Tumor Escape. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed death-ligand 1 (PD-L1), a critical immune checkpoint ligand, is a transmembrane protein synthesized in the endoplasmic reticulum of tumor cells and transported to the plasma membrane to interact with programmed death 1 (PD-1) expressed on T cell surface. This interaction delivers coinhibitory signals to T cells, thereby suppressing their function and allowing evasion of antitumor immunity. Most companion or complementary diagnostic devices for assessing PD-L1 expression levels in tumor cells used in the clinic or in clinical trials require membranous staining. However, the mechanism driving PD-L1 translocation to the plasma membrane after de novo synthesis is poorly understood. Herein, we showed that mind bomb homolog 2 (MIB2) is required for PD-L1 transportation from the trans-Golgi network (TGN) to the plasma membrane of cancer cells. MIB2 deficiency led to fewer PD-L1 proteins on the tumor cell surface and promoted antitumor immunity in mice. Mechanistically, MIB2 catalyzed nonproteolytic K63-linked ubiquitination of PD-L1, facilitating PD-L1 trafficking through Ras-associated binding 8-mediated (RAB8-mediated) exocytosis from the TGN to the plasma membrane, where it bound PD-1 extrinsically to prevent tumor cell killing by T cells. Our findings demonstrate that nonproteolytic ubiquitination of PD-L1 by MIB2 is required for its transportation to the plasma membrane and tumor cell immune evasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenTumor EscapeAnimalsMiceCell Line, TumorCell MembraneImmune EvasionProgrammed Cell Death 1 ReceptorUbiquitinationUbiquitin-Protein Ligases

Stichwörter der Autor:innen

CancerCancer immunotherapyCell BiologyCellular immune responseOncology

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 ReceptorCD274 protein, humanMib2 protein, mouseUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Medicine, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Department of Cardiovascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Clinical Center for Gene Diagnosis and Therapy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Department of Molecular Cell Biology, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • School of Transportation, Southeast University, Nanjing, Jiangsu, China.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Yu, X., Li, W., Liu, H., Wang, X., Coarfa, C., Cheng, C., Yu, X., Zeng, Z., Cao, Y., Young, K. H., & Li, Y. (2023). PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. Journal of Clinical Investigation. https://doi.org/10.1172/jci160456

Vancouver

Yu X, Li W, Liu H, Wang X, Coarfa C, Cheng C, et al. PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. Journal of Clinical Investigation. 2023. doi:10.1172/jci160456

BibTeX
@article{Yu2023,
  author = {Yu, Xinfang and Li, Wei and Liu, Haidan and Wang, Xu and Coarfa, Cristian and Cheng, Chao and Yu, Xinlian and Zeng, Zhaoyang and Cao, Ya and Young, Ken H and Li, Yong},
  title = {PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci160456}
}
Kostenlos starten →